Narcolepsy Drug Market

1. Narcolepsy Drug Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2030 Increased awareness about sleeping disorders, changing lifestyle and increase in government initiative to further create awareness are key drivers for Global Narcolepsy Drug Market. Narcolepsy Drug Market is valued around USD 2.65 Billion in 2019 and expected to reach USD 6.48 Billion by 2030 with the CAGR of 8.4% over the forecast period. Narcolepsy drugs are used for the treatment of neurological disorder named narcolepsy and also used for the treatment of sleep apnea. Narcolepsy is a condition which hampers the sleeping patterns and sleep quality of an individual with further advancement includes lack of muscle strength, hallucination and others. All the symptoms can be fatal in a long term with undiagnosed nature of the disease for a long period of time owing to the low prevalence rate and lack of proper knowledge about it. Due to the undiagnosed nature of disease it is also classified into orphan disease. Global Narcolepsy Drug Market report is segmented on the basis of disease type, diagnosis, drug type and by regional. Based upon disease type, the narcolepsy drug market is fragmented into narcolepsy type I and narcolepsy type II. On the basis of diagnosis, the market is categorized into Polysomnogram, and Multiple Sleep Latency Test. Based on drug type, the market is fragmented into Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others. The regional bifurcation of countries includes North America, Europe, Asia-Pacific, and RoW which are further segmented into major countries such as U.S., UK, France, and others. The narcolepsy drugs market is mainly driven by the changing lifestyle among young individuals with increased consumption of alcohol, tobacco, smoking and other which disturbs the sleeping patterns. Moreover, rising stress level and amplification in public awareness about various sleep disorders are also act as the major driving factors. Moreover, increase in government initiatives to create awareness about orphan disease as well as life threatening symptoms are also likely to promote market growth. However, lack of awareness, diagnosis & treatment among people are expected to inhibit the market growth. On the other hand, increase in research & development activities along with FDA approvals are likely to create new avenues in the market. Download sample copy of this report at https://www.nextmsc.com/Narcolepsy-Drug- Market/request-sample The developed regions such as North America and Europe are expected to hold the major market share owing to the presence of major market players in the region together with increasing FDA approvals to the new & advanced drugs as well as presence of well- established healthcare facilities & infrastructure. Moreover, Asia Pacific is expected to

2. dominate the narcolepsy drug market in terms of growth rate owing to the developing healthcare facilities. In addition, improved public awareness about sleep disorder along with surge in disposable income is also expected to fuel the market growth. The major market players profiled in the narcolepsy drug market includes Addrenex Pharmaceuticals, Arena Pharmaceuticals, Shire Plc, Teva Pharmaceutical Industries Ltd., Bioprojet, Ligand Pharmaceuticals, Jazz Pharmaceuticals Plc., and Graymark Healthcare, Inc among others. About Us: Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics. We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services provide an excellent client experience and ensure right strategic decision making for businesses. Contact US: Joseph Lawrence (Head - Client Engagement & Servicing) Joseph@nextmsc.com